Navigation Links
Safety Threat to Rochester Still Remains Despite Approval Of Canadian Pacific's Railroad Acquisition Of DM&E
Date:9/30/2008

co-medical director of Mayo Clinic Medical Transport.

In 2002, a Canadian Pacific Railway train derailed near Minot, N.D., causing violent rupture to five tankers and spilling 220,000 gallons of anhydrous ammonia. Roughly 11,600 people were evacuated or asked to stay in their homes. The plume of corrosive gas gradually expanded five miles downwind. More than 1,100 people were treated for chemical burns, mainly to their eyes, nasal passage, throat and lungs. The DM&E rail line runs through the city of Rochester within a few hundred yards of medical facilities, senior living centers and major businesses. Disaster preparedness officials in Rochester have said a similar accident to the one in Minot would be devastating, as hundreds or thousands of patients and vulnerable individuals would be unable to escape.

"Because of the STB's refusal to address our community's safety concerns, we will continue oppose any plan that would jeopardize our safety and vitality by increasing train traffic, speed, and shipments of hazardous materials," said Rochester Mayor Ardell Brede.

The Rochester Coalition continues to engage in an ongoing dialogue with officials from Canadian Pacific Railway, eager to hear specifics of their plans to ensure public safety and ensure the long-term economic vitality of southeastern Minnesota.

The Rochester Coalition represents the city of Rochester, Olmsted County, the Rochester Area Chamber of Commerce and Mayo Clinic. For more information, visit http://www.protectrochester.com.

Background

For more than a decade, DM&E has pursued a major rail expansion across southern Minnesota and South Dakota, hoping to haul large amounts of coal from Wyoming's Powder River Basin to power plants in the Midwest and East. Unable to secure private financing for the project, DM&E sought the largest federal loan to a private company in American history -- a $2.3 billion l
'/>"/>

SOURCE Rochester Coalition
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. China-Biotics, Inc. Sees No Impact on Its Business From Dairy Products Safety Concerns
2. 27 National Nursing Organizations Join Together to Commission a Study of the Impact of Advanced Practice Registered Nurses on Healthcare Quality, Safety, and Effectiveness
3. Leapfrog Groups 2008 Top Hospitals Excel at Patient Safety
4. DIA/FDA/PhRMA Drug Safety Conference: Planning the Lifecycle of Safety Evaluation
5. Record Upsurge in States Child Safety Seat Usage Marks Child Passenger Safety Week
6. Home Safety Council(R) Applauds Creation of Falls Prevention Awareness Day
7. Underwriters Laboratories to Host Global Leadership Conference on Fire and Life Safety
8. Spansion Wins Gold Award for Occupational Safety and Health in Malaysia
9. Red Cross Urges Safety in Wake of Hurricane Ike
10. Safety Gear a Must to Prevent Kids Sports Injuries
11. Pennsylvania Governor Rendell Says Businesses Saved $300 Million With Workplace Safety Program
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:New study finds low rate of injuries at overnight summer camp 2Health News:DNA Test May Detect Immune Disorder in Infants 2Health News:Soy Beneficial for Breast Cancer Survivors: Study 2Health News:Soy Beneficial for Breast Cancer Survivors: Study 3Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 2Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 3Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 4Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 5Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 6Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 7Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 8Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 9Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 10Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 11Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 12Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 13Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 14Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 15Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 16Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 17Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 18Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 19Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 20Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 21Health News:Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends) 2Health News:Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends) 3Health News:Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends) 4Health News:Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends) 5Health News:Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends) 6
Other Medicine News:Health News:Anpath Group, Inc. Announces Appointments of David V. Gilroy and Paul A. Boyer to Board of Directors 2Health News:Anpath Group, Inc. Announces Appointments of David V. Gilroy and Paul A. Boyer to Board of Directors 3Health News:Anpath Group, Inc. Announces Appointments of David V. Gilroy and Paul A. Boyer to Board of Directors 4Health News:Gatorade and NFL Launch Third Annual Beat the Heat Campaign to Educate Youth Football Players and Coaches About Heat-Related Illnesses 2Health News:Gatorade and NFL Launch Third Annual Beat the Heat Campaign to Educate Youth Football Players and Coaches About Heat-Related Illnesses 3Health News:Florida KidCare News Conference and Back to School Enrollment Fair 2Health News:Delta Dental Foundation Calls for Applicants for Annual Community Mini-Grant Program 2Health News:Disparities in prostate cancer treatment suggest ways to improve care 2Health News:No substitute for hard work: Creatine supplementation does not improve exercise outcomes in COPD 2
Other Medicine Technology:Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic,Drug to Treat Viral Eye Infection 2New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 2New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 3New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 4New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 5New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 6New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 7New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 8